Navigation Links
N.C. Biotech Center Launches Larger Loans
Date:7/9/2008

Support doubled to take product ideas to market

RESEARCH TRIANGLE PARK, N.C., July 9 /PRNewswire-USNewswire/ -- Start-up biotech companies may qualify for up to $1 million in loans under a program unveiled this week by the North Carolina Biotechnology Center.

The loans are part of an expanded program funded by the Biotechnology Center for companies in North Carolina. The funds give early-stage companies a boost before they become competitive for angel or venture-capital investment. Separate loans support company inception, certain types of research and corporate growth.

The overall dollar amounts are more than two times larger than in years past.

"Building a viable biotechnology company requires years of struggle and millions of dollars," said John Richert, vice president of the Business and Technology Development Program, "and the costs keep rising."

"So we've not only increased the caps on these offerings, but we've also made some revisions to fill funding gaps and stay ahead of the changing dynamics of the marketplace."

The revisions became effective July 1 and were a product of conversations with members of the venture-capital community, university technology-transfer offices and with entrepreneurs to learn how the Biotechnology Center could improve its support of companies at different stages of development.

Getting Started

The first change was to eliminate two programs that awarded either $25,000 or $50,000 to fund corporate spin-outs or university start-ups. Those two programs are now replaced with the Company Inception Loan of $50,000.

The business-inception package also includes a $50,000 Technology Enhancement Grant for technology-transfer offices at North Carolina universities.

"That's to help them make technologies they may have on their shelves more licensable," said Richert.

Supporting Research

In the research-loan offerings, the Biotechnology Center's Small Busi
'/>"/>

SOURCE North Carolina Biotechnology Center
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. FDA Grants Epeius Biotechnologies Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas
2. Genetic Engineering & Biotechnology News reports on novel hit-to-lead drug discovery
3. Epeius Biotechnologies Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatment of Osteosarcoma
4. Dietitian Mary Lee Chin Comments on Proven Value and Safety of Food Biotechnology in New Online Video
5. N.C. Biotechnology Center Launches Industrial Fellowship Program
6. ThirdBiotech Launches Research Institute to Promote Formation and Growth of Arizona-Based Biotech Companies
7. Lixte Biotechnology Holdings Announces Extension of Its Cooperative Research and Development Agreement With The National Institute of Neurological Disorders and Stroke, National Institutes of Health, for Development of Anti-Brain Cancer Drugs
8. FierceBiotech Names NanoBio Corporation as One of the Fierce 15 Biotech Companies of 2008
9. Tolerx Named as One of the Fierce 15 Biotech Companies of 2008
10. Rentschler Biotechnologie erweitert Kapazitten fr Produktion in Sugetierzellen
11. Rentschler Biotechnologie Extends Capacities for Mammalian Cell Culture Manufacturing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... , July 31, 2014 Research ... "Global Genomics Market 2014-2018" report to their ... Genomics is the study of the genetic material ... be a strong basis for the discovery and development ... human diseases or health conditions. Genomics is supported by ...
(Date:7/31/2014)... Calif. (PRWEB) July 31, 2014 Held ... diagnosed patients with an overview of the disease and ... of drug side effects, as well as updates on ... grateful to Dr. Sandy Srinivas for organizing this educational ... of kidney cancer. “Sandy and her colleagues have put ...
(Date:7/31/2014)... 2014   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade hypothermic storage and ... shipping products for cells and tissues, today announced ... will be released on Thursday, August 7, 2014, and ... live webcast at 4:30 p.m. ET that afternoon. Management ...
(Date:7/30/2014)... , July 30, 2014 Regulus ... biopharmaceutical company leading the discovery and development of innovative ... financial results and highlights for the quarter ended June ... U.S. financial markets close. Regulus will ... 6, 2014, at 5:00 pm Eastern Daylight Time to ...
Breaking Biology Technology:Global Genomics Market 2014-2018: Key Vendors are F. Hoffmann-La Roche, Life Technologies, Qiagen and Illumina 2BioLife Solutions to Report Financial Results for Second Quarter 2014 and Provide Business Update on August 7, 2014 2Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 3
... 2009 Senomyx, Inc. (Nasdaq: SNMX ) will ... 7, 2009 before the opening of the U.S. financial markets. ... a live Internet broadcast that will provide a corporate update ... same day at 11:00 a.m. Eastern Time (8:00 a.m. Pacific ...
... Fla., April 22 OmniComm Systems, Inc. (OTC Bulletin ... the clinical trials market today announced its results of ... the first quarter of 2009 increased approximately 139% to ... 2008. Gross profit margin improved to 79.5% for the ...
... (Nasdaq CM: INSM ), a biopharmaceutical ... call on Wednesday, May 13th at 8:30 AM ET, ... 2009. Insmed intends to issue its quarterly financial ... 13th.To participate in the live conference call, please dial ...
Cached Biology Technology:SENOMYX, INC. FIRST QUARTER 2009 EARNINGS CONFERENCE CALL SCHEDULED FOR MAY 7, 2009 2OmniComm Systems Announces 1st Quarter Results of Operations 2OmniComm Systems Announces 1st Quarter Results of Operations 3Insmed to Host First Quarter 2009 Conference Call 2
(Date:7/31/2014)... of animal models against the highly infectious and virulent ... disease that kills approximately 30,000 Americans annually. The research ... Immunity . , In the study, the vaccine ... toxins produced by C. difficile , as well ... that mimics the human disease, after only two immunizations. ...
(Date:7/31/2014)... exposure to loud noise alters how the brain ... speech sounds, according to neuroscientists at The University ... published this week in Ear and Hearing ... noise-induced hearing loss affects the brain,s recognition of ... all corners of the population, affecting an estimated ...
(Date:7/31/2014)... step has been made to help better identify and treat ... abnormal narrowing and enlarging of medium sized arteries in the ... other organs causing damage. In a new report appearing in ... , scientists provide evidence that that FMD may not be ... show a connection to abnormalities of bones and joints, as ...
Breaking Biology News(10 mins):C. difficile vaccine proves safe, 100 percent effective in animal models 2UT Dallas study reveals effect of loud noises on brain 2Scientists discover biochemical mechanisms contributing to fibromuscular dysplasia 2
... (CHICAGO - Sept. 30, 2009) U.S. Environmental Protection Agency,s ... of a dioxin exposure study conducted by the University ... the study was conducted well and provided useful, scientifically ... to help EPA fully evaluate human exposure to levels ...
... KINSTON, N.C., Oct. 1 Spatial Integrated Systems, ... integration of solutions incorporating next-generation digital 3D data ... United States patent application has been published for ... 3-dimensional image rendering" under Publication No. US2009/0169095A1. , ...
... University of Warwick and Rothamsted Research have been awarded ... (BBSRC) in partnership with Syngenta, to research the decline ... have fallen by 10-15% over the last 2 years; ... 30% for 2008. Since the declines were first reported ...
Cached Biology News:EPA reviews Univ. of Michigan dioxin study 2Spatial Integrated Systems, Inc. Files Patent Application 2£1 million award to address honeybee decline 2£1 million award to address honeybee decline 3
SAPK/JNK Antibody...
Mouse monoclonal [DJR3] to DcR1 (Biotin) ( Abpromise for all tested applications). entrezGeneID: 8794 SwissProtID: O14798...
Tris-EDTA Buffer Solution, 1X, pH 8.0, sterile, Molecular Biology Grade...
Component in MasterPure™ Purification Kits...
Biology Products: